Trials / Recruiting
RecruitingNCT06415474
Evolution of the Lymphocyte Phenotype in Patients with Infection in Intensive Care Unit
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients admitted for polytrauma, severe neurological injury, post-operative monitoring or sepsis/septic shock present with significant inflammation, leading to immunoparalysis, which is responsible for infection, particularly prolonged infection. A study of their lymphocyte phenotype over time could help explore the phenomenon of immunoparalysis.
Conditions
- Patients Undergoing Esophagectomy
- Patients with Severe Polytrauma
- Patients with Severe Neurological Lesion
- Patients with Abdominal Infection
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lymphocyte Phenotyping Procedure | For all patients, lymphocyte phenotyping will be performed on biological samples taken on D0, D7 and the day of discharge. In case of infection, phenotyping will also be performed on the day of infection diagnosis and on the day corresponding to half the duration of antibiotic therapy. For phenotyping, only 1.5 mL will be used. In case of infection, an additional 1mL will be collected (0.5mL on the day of inclusion diagnosis and 0.5 mL on the day corresponding to half the duration of antibiotic therapy). Blood is collected during sampling, which takes place several times a day as part of the standard management of these patients. It is important to note that phenotyping is not routinely performed as part of routine care. An additional tube is therefore taken specifically for this analysis, but this is done without the need for an additional puncture. |
Timeline
- Start date
- 2024-10-03
- Primary completion
- 2026-10-03
- Completion
- 2026-11-03
- First posted
- 2024-05-16
- Last updated
- 2025-02-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06415474. Inclusion in this directory is not an endorsement.